Licensing & Pipeline.

We license clinical-stage assets and leverage our tech-driven platform to develop them, generating more value per program by reaching the next value inflection point in the development lifecycle faster and more efficiently. By developing our portfolio assets faster than industry norms, we can take more shots on goal, increasing the likelihood of success for us and our partners.